Are you kidding? NNVC hasn't even distributed samples of Herpescide to any of the university researchers yet.
The most optimistic possible schedule is:
NNVC finally gets its samples to the universities and gets the cell and animal testing done needed to select which variant of Herpescide to do tox on. This will happen, at the earliest, by mid 2017.
NNVC gets tox done. This will happen at the earliest by the end of 2017. If it happens.
NNVC gets IND approval. Mid 2018 at the earliest.
Clinical trials being. Late 2018 at the earliest.
Sometime well before clinical trials begin NNVC will have to sell a lot more shares to raise more money. And yes, this is a very optimistic schedule.
News 
Market Data 
Discover 
